Literature DB >> 3336288

Glutamine and glucose metabolism in human peripheral lymphocytes.

M S Ardawi1.   

Abstract

The metabolism of glutamine and glucose in resting and concanavalin A-stimulated human peripheral lymphocytes was investigated. Glutamine was metabolized at a high rate by resting and mitogen-stimulated human peripheral lymphocytes and the major end-products of glutamine metabolism were glutamate, aspartate, CO2, and ammonia: the carbon from glutamine may contribute about 21% to respiration. Concanavalin A enhanced the formation of all end-products except glutamate, indicating that more glutamine was metabolized beyond the stage of glutamate in the mitogen-stimulated cells. Mitogenic stimulation caused an increase in the rates of glucose utilization, lactate production and 14CO2 from variously labeled [14C] glucose. Concanavalin A caused an increase in the oxidation of pyruvate as indicated by the enhanced release of 14CO2 from [2-14C]-, [3,4-14C]-, and [6-14C]-glucose. When both glucose and glutamine were presented to the cells, the rates of utilization of both substrates increased and the increased rates of glucose and glutamine utilization could be accounted for mainly by increased rates of lactate and glutamate production, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3336288     DOI: 10.1016/0026-0495(88)90036-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  32 in total

Review 1.  Nutritional aspects of immunosuppression in athletes.

Authors:  N C Bishop; A K Blannin; N P Walsh; P J Robson; M Gleeson
Journal:  Sports Med       Date:  1999-09       Impact factor: 11.136

2.  Amino acid metabolism during batch culture of a murine hybridoma, AFP-27.

Authors:  C P Marquis; J P Barford; C Harbour
Journal:  Cytotechnology       Date:  1996-06       Impact factor: 2.058

3.  Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.

Authors:  Erikka L Carr; Alina Kelman; Glendon S Wu; Ravindra Gopaul; Emilee Senkevitch; Anahit Aghvanyan; Achmed M Turay; Kenneth A Frauwirth
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

Review 4.  Glutamine and cancer: cell biology, physiology, and clinical opportunities.

Authors:  Christopher T Hensley; Ajla T Wasti; Ralph J DeBerardinis
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

5.  Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer.

Authors:  S Yoshida; M Matsui; Y Shirouzu; H Fujita; H Yamana; K Shirouzu
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

6.  Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.

Authors:  Sivabalan Manivannan; Victoria K Baxter; Kimberly L W Schultz; Barbara S Slusher; Diane E Griffin
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

7.  Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage.

Authors:  Eran Israeli; Eduard Berenshtein; Dov Wengrower; Larisa Aptekar; Ron Kohen; Gershom Zajicek; Eran Goldin
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.

Authors:  P G Boelens; J C M Fonk; A P J Houdijk; R J Scheper; H J T H M Haarman; S Meijer; P A M Van Leeuwen; B M E von Blomberg-van der Flier
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 9.  Metabolic regulation of immune responses.

Authors:  Kirthana Ganeshan; Ajay Chawla
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

10.  Utilization of alanyl-L-glutamine and glycyl-L-glutamine during long-term parenteral nutrition in the growing rat.

Authors:  M Neuhäuser-Berthold; H Eufinger
Journal:  Amino Acids       Date:  1992-10       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.